Is Castellum Inc (AMEX:CTM) stock a better investment at this time?

Currently, Castellum Inc’s (CTM) stock is trading at $1.28, marking a fall of -3.03% from last night’s close. At this price, the stock is -54.77% below its 52-week high of $2.83 and 952.63% above its 52-week low of $0.12. Based on the past 30-day period, the stock price is -16.35% below the high and +27.94% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CTM’s SMA-200 is $0.8546.

As well, it is important to consider CTM stock ratios such as price-to-sales, which is currently 2.58.CTM’s price to book ratio for the most recent quarter was 4.22, resulting in an 8.75 price to cash per share for the period.

How does Castellum Inc (CTM) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 3 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.00 in simple terms.

Castellum Inc (AMEX: CTM) Ownership Details

I will give a breakdown of the key shareholders in Castellum Inc (CTM). Recent figures show that the company’s insiders hold 25.42% of shares. A total of 30 institutional investors hold shares in the company, making 3.67% of its stock and 4.93% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Vanguard Group Inc holding total of 639.63 shares that make 0.13% of the company’s total number of shares and are currently priced at 0.82 million.

The securities firm Bank Of New York Mellon Corporation holds 600.0 shares of CTM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.12% , and the holding percentage of shares is valued at 0.77 million.

An overview of Castellum Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Castellum Inc (CTM) traded 3,225,194 shares per day, with a moving average of $1.2487 and price change of +0.2450. With the moving average of $1.1543 and a price change of +0.2750, about 2,471,240 shares changed hands on average over the past 50 days. Finally, CTM’s 100-day average volume is 2,395,001 shares, alongside a moving average of $1.0998 and a price change of -0.2150.

Hot this week

Procept BioRobotics Corp (PRCT)’s stock chart: A technical perspective

While Procept BioRobotics Corp has underperformed by -1.13%, investors...

Chewy Inc (CHWY)’s stock performance: a year in review

While Chewy Inc has overperformed by 2.45%, investors are...

Arcus Biosciences Inc (RCUS)’s stock price in review: A technical analysis

While Arcus Biosciences Inc has overperformed by 0.47%, investors...

A closer look at Edgewell Personal Care Co (EPC)’s stock price trends

While Edgewell Personal Care Co has overperformed by 0.51%,...

Arrowhead Pharmaceuticals Inc (ARWR)’s stock rises to 22.34 per share

While Arrowhead Pharmaceuticals Inc has overperformed by 2.52%, investors...

Topics

Procept BioRobotics Corp (PRCT)’s stock chart: A technical perspective

While Procept BioRobotics Corp has underperformed by -1.13%, investors...

Chewy Inc (CHWY)’s stock performance: a year in review

While Chewy Inc has overperformed by 2.45%, investors are...

Arcus Biosciences Inc (RCUS)’s stock price in review: A technical analysis

While Arcus Biosciences Inc has overperformed by 0.47%, investors...

A closer look at Edgewell Personal Care Co (EPC)’s stock price trends

While Edgewell Personal Care Co has overperformed by 0.51%,...

Arrowhead Pharmaceuticals Inc (ARWR)’s stock rises to 22.34 per share

While Arrowhead Pharmaceuticals Inc has overperformed by 2.52%, investors...

Yext Inc (YEXT) stock analysis: A comprehensive overview

While Yext Inc has overperformed by 0.22%, investors are...

Zevra Therapeutics Inc (ZVRA)’s stock price range in the last year

While Zevra Therapeutics Inc has underperformed by -0.64%, investors...

Kontoor Brands Inc (KTB) stock: A year of ups and downs

While Kontoor Brands Inc has underperformed by -1.58%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.